GLP-1 is a hormone that regulates blood sugar, appetite and digestion. A diet rich in high-fiber foods may help your body ...

Findings indicate that excessive somatostatin inhibits glucagon secretion in type 1 diabetes, offering a novel target for hypoglycemia management strategies.

Some weight loss drugs may cause hair loss. While it’s typically a temporary side effect, it can affect your confidence.

The Semaglutide market is projected to expand from US$ 27.15 billion in 2024 to US$ 61.7 billion by 2033, with a CAGR of 9.55% from 2025. Driven by rising obesity and type 2 diabetes incidences, the ...

Explore the growing GLP-1 agonists market, driven by rising diabetes and obesity rates. Discover advancements in therapies like Tirzepatide and GZR18, offering both glycemic control and weight loss ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

The basal secretion of glucagon stabilizes blood glucose levels, counterbalancing the basal secretion of insulin. 1 Glucagon stimulates the liver to produce more glucose, thus maintaining glucose ...

However, glucagon secretion was decreased more than twofold in the aTKO islets compared to controls. Out of five proteins recently reported to be involved in alpha cell glucagon expression, only one, ...

About the study The present study used a widely recognized type 1 diabetes mouse model, the non-obese diabetic or NOD mice, to understand the impaired hypoglycemia-induced secretion of glucagon in ...

Beta cells play a key role in the pathogenesis of both Type 1 and Type 2 diabetes. However, pancreatic islets also have alpha cells that produce the hormone glucagon, which acts to raise glucose blood ...